Our country non- clear marrow transplant study pass by ten year

Our country non- clear marrow transplant, study, pass by ten year
Our country non- clear marrow transplant, study, pass by ten year
The intersection of reporter and Lu Han hold in Beijing from May 29 national non- clear the intersection of marrow and different the intersection of gene and hematopoietic stem cell transplant at the scientific seminar learning on the fifth, our country has succeeded in launching the hematopoietic stem cell of different gene of non- clear marrow and transplanting more than 1000 over the past 10 years, the long-term survival rate of the case is more than 70%. According to the introduction of expert participating in the conference, tradition transplant mode need, implement, cause death setting to patient free, chemotherapy of the dosage almost before transplantation, in the hope of killing and killing tumour cells to the greatest extent, but damage the patient greatly, apt to initiate many kinds of complication, suitable for the intersection of body and the intersection of terms and better, the intersection of age and under 45 years old, the intersection of course of disease and short main the intersection of internal organs and the intersection of function and good patient only. The difference of non- clear marrow transplantation lies in, but remove patient's lymphocytic system completely but the systematic part of marrow is removed. The hematopoietic stem cell of different gene of non- clear marrow has transplanted and lightened the chemotherapy intensity, has reduced mortality, widen and transplant indication, make it old (most 75) , the weak, internal organs function has patients that damages to have an opportunity to receive treatment too. At present, how to reduce and transplant complication and reduce and transplant the expenses is difficult problems to be solved urgently in employing of this technology. The seminar is sponsored by 307 hospitals of PLA man.


|